Targeting Tyrosinase Engineered with a Highly Avid TCR Effective In Vivo Tumor Treatment When Both CD4 and CD8 T Cells Mediate Equally
暂无分享,去创建一个
Zhili | W. Burns | J. Wargo | S. Rosenberg | R. Morgan | T. Frankel | N. Restifo | P. Peng | D. Chinnasamy | Zheng | Zheng